Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page
- Check7 days agoChange DetectedMetadata and navigation on the study record page were updated. The changes introduce a new attribution line for Jane N. Winter and a Last Verified label, remove older references (e.g., Northwestern University, Intervention/Treatment, Revision: v3.5.5), and add new items such as How to Read a Study Record, Common Questions, How to Join a Study, plus a new Revision: v3.6.0.SummaryDifference1%

- Check14 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates an administrative update to the study record rather than substantive changes to content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a new Study Protocol and Statistical Analysis Plan PDF under Study Documents, with associated metadata. This expands access to the study’s methodological documentation for review by interested readers.SummaryDifference69%

- Check56 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a website/version release change rather than any modification to the clinical study information.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check92 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.